By Melissa Lipman ( November 23, 2009, 5:10 PM EST) -- The U.S. Food and Drug Administration has launched an expedited safety review of sibutramine based on a recent study showing that some patients taking the weight loss drug, which Abbott Laboratories markets as Meridia, have a higher rate of heart attacks, strokes and other cardiovascular events....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.